BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16237647)

  • 1. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.
    Hermans PW; Hazelzet JA
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S453-8. PubMed ID: 16237647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
    Ma Z; Paek D; Oh CK
    Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.
    Hermans PW; Hibberd ML; Booy R; Daramola O; Hazelzet JA; de Groot R; Levin M
    Lancet; 1999 Aug; 354(9178):556-60. PubMed ID: 10470700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z; Jhun B; Jung SY; Oh CK
    J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H; Wallmark K; Jern S; Karlsson L
    Thromb Res; 2008; 121(6):793-7. PubMed ID: 17884148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene.
    Testa R; Bonfigli AR; Sirolla C; Marra M; Boemi M; Mari D; Sacchi E; Dolci A; Catalano A; Procopio A; Ceriello A
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):220-6. PubMed ID: 17433639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
    Geishofer G; Binder A; Müller M; Zöhrer B; Resch B; Müller W; Faber J; Finn A; Endler G; Mannhalter C; Zenz W;
    Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.
    Solá E; Vayá A; España F; Castelló R; Ramón LA; Hernández-Mijares A; Vicente V; Estellés A
    Thromb Res; 2008; 122(3):320-7. PubMed ID: 18037477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis.
    Wingeyer SP; de Larrañaga G; Cunto E; Fontana L; Nogueras C; San Juan J
    Thromb Res; 2010 Apr; 125(4):367-9. PubMed ID: 19410276
    [No Abstract]   [Full Text] [Related]  

  • 15. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
    Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
    Iribarren JL; Jimenez JJ; Hernández D; Brouard M; Riverol D; Lorente L; de La Llana R; Nassar I; Perez R; Martinez R; Mora ML
    Anesthesiology; 2008 Apr; 108(4):596-602. PubMed ID: 18362590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In meningococcal disease 4G bad, 5G good.
    Baines PB; Carrol ED
    Crit Care Med; 2003 Dec; 31(12):2813-4. PubMed ID: 14668625
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A; Ulu A; Cam R; Akar N
    J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
    Wiwanitkit V
    Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.